Media Center

His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, met with top graduates from the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) Class of 2024.

His Highness commended the MBRU graduates for their dedication and perseverance in striving for excellence throughout their educational journey. He urged them to continue their commitment to excellence as they transition into their professional careers, noting that their achievements will inspire future generations of medical professionals. His Highness encouraged them to remain steadfast in their pursuit of knowledge, as their contributions will shape the future of healthcare and enhance the well-being of society.

Highlighting efforts to reinforce the UAE and Dubai's position as a center for excellence in medicine, health sciences, and scientific research, His Highness underscored the role of institutions like MBRU as well as healthcare professionals in the nation's progress. MBRU is a pioneering institution that significantly contributes to expanding scientific research and innovation, as well as empowering the next generation of national talent, he added.

The meeting was held in the presence of His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai, Deputy Prime Minister and Minister of Defence of the UAE, and Chairman of The Executive Council of Dubai.

Commenting on the occasion, His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chancellor of MBRU and Chairman of the Board of Directors of Dubai Health, said: “I extend my deepest gratitude to His Highness Sheikh Mohammed bin Rashid Al Maktoum for his unwavering support. His visionary leadership in establishing Dubai Health and his dedication to advancing healthcare and education in Dubai have been instrumental in shaping the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU). We take immense pride in our graduates who embody the values and aspirations of our nation. We are confident they will make significant contributions to the field of healthcare, both locally and on the global stage.”

Also present at the meeting were Her Excellency Dr. Raja Easa Al Gurg, Chairperson of the MBRU Council and Dubai Health Board Member; His Excellency Dr. Amer Sharif, President of MBRU and CEO of Dubai Health; and Professor Alawi Alsheikh-Ali, Provost of MBRU and, Deputy CEO and Chief Academic Officer of Dubai Health.

At the event, Her Excellency Dr. Raja Easa Al Gurg said: “We extend our sincerest thanks and profound gratitude to His Highness Sheikh Mohammed bin Rashid Al Maktoum for meeting our graduates and celebrating their remarkable achievements. This moment is a profound honor for our graduates. Inspired by a visionary leader whose foresight has shaped the trajectory of healthcare and education, our graduates now stand as inspiring role models for excellence across all fields.”

Addressing the gathering, His Excellency Dr. Amer Sharif shared: “The gathering highlights His Highness Sheikh Mohammed bin Rashid Al Maktoum’s commitment to fostering excellence and innovation in the field of medicine and health sciences. Under his vision, our integrated academic health system was established to empower all learners, from students to experienced clinicians, with a scholarly-driven ethos that not only advances the healthcare field but directly translates to better care for our patients at Dubai Health. We are immensely proud of the accomplishments of our graduates and alumni and remain dedicated to nurturing talent and developing the next generation of healthcare professionals.”

The 2024 graduating class from MBRU included 153 graduates from 24 programs, spanning the Hamdan Bin Mohammed College of Dental Medicine, the College of Medicine, the College of Nursing and Midwifery, and the Deanship of Graduate Medical Education. Nearly 40% of the graduates were young Emiratis, with the remaining graduates representing 27 different nationalities. The diversity of the graduating class highlights MBRU’s commitment to advancing healthcare on a local and global scale.

The Mohammed Bin Rashid Space Centre (MBRSC) announced the signing of an agreement with Dubai Health to cooperate in the provision of an optimum environment to ensure the health and safety of astronauts, in addition to enhancing innovation in health sciences. The agreement was signed by H.E. Salem Humaid AlMarri, Director General, MBRSC, and H.E. Dr. Amer Sharif, CEO, Dubai Health, at the Centre’s headquarters recently.

H.E. Salem Humaid AlMarri, Director General, MBRSC, said, “The health and safety of our astronauts are paramount, and this agreement will ensure that they receive the best possible care before, during, and after their missions. In the rapidly evolving space sector, collaboration is the way forward. By integrating our efforts with Dubai Health, we are not only enhancing the well-being of our astronauts but also pushing the boundaries of space healthcare and driving innovation in health sciences. This partnership not only strengthens our capabilities but also underscores the UAE’s commitment to pioneering advancements in space and health technologies.”

H.E. Dr. Amer Sharif, CEO, Dubai Health, said, “Emirati astronauts are a source of national pride and a significant asset for the UAE in advancing knowledge, scientific capabilities, as well as raising our great country's profile on a global stage. At Dubai Health, we are proud to play a direct role in ensuring the health and safety of our astronauts by offering an environment for quality healthcare, providing comprehensive health assessments and supporting the monitoring of health during space missions.”

He further commented, “This agreement aligns with our strategic objectives, encompassing key pillars of care, learning and discovery to elevate the standard of care and to advance health for humanity, whilst helping to strengthen our nation’s healthcare and space capabilities.”

The agreement outlines a range of initiatives by MBRSC to ensure the health and well-being of astronauts. In cooperation with Dubai Health, the Centre will conduct comprehensive health assessments for astronauts prior to mission deployment, including medical examinations, screenings, and evaluations to ensure fitness for space travel.

Furthermore, MBRSC will provide astronaut training programs in collaboration with Dubai Health, ensuring that astronauts are adequately prepared for health-related protocols and emergencies, in addition to integration and exchange of health data with healthcare providers for comprehensive astronaut care. Both entities will also work together to enhance medical technologies and methodologies related to space healthcare, fostering continuous improvement.

Dubai Chambers announced that it has signed a Memorandum of Understanding (MoU) with Al Jalila Foundation, donating AED15 million to support the Hamdan Bin Rashid Cancer Hospital, the first fully integrated and comprehensive cancer hospital in Dubai.

Dubai Chambers’ donation to the Hamdan Bin Rashid Cancer Hospital exemplifies their unwavering commitment to enhancing community welfare and supporting critical initiatives that improve quality of life.

The MoU was signed by His Excellency Abdul Aziz Abdulla Al Ghurair, Chairman of Dubai Chambers, and Her Excellency Dr. Raja Easa Al Gurg, Chairperson of Al Jalila Foundation Board of Directors and Dubai Health Board Member, at the Dubai Chambers’ headquarters.

His Excellency Abdul Aziz Abdulla Al Ghurair said: “In line with the vision of His Highness Sheikh Mohammed Bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, to strengthen social responsibility, Dubai Chambers is keen to support national projects that contribute to improving the quality of life and enhancing community services, thereby fostering social and economic development.”

Al Ghurair added: “Our cooperation with Al Jalila Foundation to support the Hamdan Bin Rashid Cancer Hospital reflects our commitment to the principles of social responsibility and the importance of charitable and humanitarian work, as part of our ongoing efforts to effectively contribute to serving the community.”

Expressing her gratitude for the donation, Her Excellency Dr. Raja Al Gurg said: “We are grateful to Dubai Chambers for their generous contribution toward establishing Dubai’s first comprehensive cancer hospital. Through this collaboration and the power of giving, Al Jalila Foundation is paving the way for enhanced care for cancer patients and their families in Dubai. This partnership aligns perfectly with our mission to foster a healthy and sustainable society, enhancing health and wellbeing through humanitarian, developmental, and community-focused efforts.”

Al Jalila Foundation is currently developing the Hamdan Bin Rashid Cancer Hospital, spanning 56,000 square meters. The hospital will feature 50 clinics, 30 clinical research areas, 60 infusion rooms, 10 urgent care rooms, five radiotherapy rooms, and 116 beds, complemented by 19 gardens spread across the campus. These gardens will offer patients space for recovery and opportunities to spend time outdoors with their families, promoting enhanced mental well-being.

The new facility will house a multidisciplinary team, including specialized nursing staff, and will provide integrated healthcare services from initial diagnosis through treatment, ensuring comprehensive care under one roof. Selected treatments and services will also be accessible to patients in their homes, ensuring continuity of affordable care and reflecting Dubai Health’s commitment to prioritizing patient needs.

DP World Foundation has donated Dh15 million to Al Jalila Foundation to support the development of the Hamdan bin Rashid Cancer Hospital, highlighting its commitment to corporate social responsibility and community welfare.
The contribution is part of DP World Foundation's broader efforts to support vital healthcare services and improve access to quality healthcare for cancer patients.
The allocated funds will support the development of Dubai's first integrated cancer hospital, scheduled to open in 2026. The advanced healthcare facility, which is being established in collaboration with the Al Jalila Foundation, will feature 50 clinics, 30 research areas, 60 infusion rooms, and 116 inpatient beds spread across a sprawling 56,000-square-metre campus.
His Excellency Nasser Abdulla Al Neyadi, Chief Officer Group Security, Government Relations & Public Affairs (GRPA), and DP World Foundation, presented the contribution during a visit to the Al Jalila Foundation, including the Mohammed Bin Rashid Biomedical Research Centre, where he met with key healthcare officials and stakeholders.
HE Al Neyadi said: "We are deeply committed to making a real difference in society, and this donation reflects our dedication to supporting healthcare institutions and ensuring that quality care is accessible to everyone. We are proud to contribute to such a respected institution leading the way in cancer care and research. Together, we aspire to foster a healthier future for all."
Dr. Amer Al Zarooni, CEO of the Al Jalila Foundation, said: "We extend heartfelt gratitude to the DP World Foundation for their generous donation towards the Hamdan Bin Rashid Cancer Hospital. The collaboration exemplifies the transformative impact of partnerships in accelerating the delivery of critical healthcare services and further emphasizes Dubai Health's commitment to improving the health and well-being of our community.
Together, with the support of our partners, we are steadfast in our dedication to transforming lives and ensuring better health for everyone."
The philanthropic arm of DP World, DP World Foundation, is committed to promoting social responsibility and supporting those in need, regardless of nationality, race, or religion. Earlier this year, DP World Foundation contributed Dh 10 million to the Mothers' Endowment Campaign launched to support the education of millions around the world.

His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chancellor of the Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU) and Chairman of the Board of Directors of Dubai Health attended the graduation ceremony of MBRU Class of 2024 on Tuesday, June 25 at the Dubai World Trade Centre.

Held under the patronage of His Highness Sheikh Ahmed bin Saeed, the graduation ceremony for the Class of 2024 honored 153 graduates from 24 programs offered by the Hamdan Bin Mohammed College of Dental Medicine, the College of Medicine, the College of Nursing and Midwifery, and the Deanship of Graduate Medical Education.

The 2024 graduating class consisted of nearly 40% young Emiratis and graduates from 27 different nationalities, highlighting MBRU's dedication to Dubai Health's broader vision of advancing health for humanity. This demonstrates MBRU's role as an emerging hub for aspiring healthcare professionals from both the UAE and around the globe.

His Highness Sheikh Ahmed bin Saeed said: As part of Dubai Health, the Mohammed Bin Rashid University of Medicine and Health Sciences continues to play a key role in fostering the next generation of innovative medical professionals in Dubai, who are equipped to enhance the quality of healthcare services in the city and adapt to future challenges. This mission aligns perfectly with the vision of His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, to establish Dubai as a global hub for healthcare and education.”

His Highness conveyed his heartfelt congratulations to the Class of 2024 for their achievements and extended his best wishes for their success as they embark on a journey to advance health for humanity

In her welcome address, Her Excellency Dr. Raja Easa Al Gurg, Chairperson of MBRU Council and Dubai Health Board Member, said: “We dedicate this honorable achievement to His Highness Sheikh Mohammed bin Rashid Al Maktoum, whose visionary leadership in enhancing healthcare for the people of the UAE serves as a profound inspiration and has laid the groundwork for our academic journey toward achieving the highest standards in advancing health for humanity.”

She added: “MBRU was founded under the directives of His Highness Sheikh Mohammed eight years ago, underscoring his unwavering commitment to the healthcare sector. His wisdom and generosity have led to the establishment of a globally connected university, founded on a vision to create an innovative, integrated healthcare education and research system that benefits the UAE and beyond.”

Addressing the gathering, His Excellency Khalfan Belhoul, Chief Executive Officer of the Dubai Future Foundation, emphasized the importance of courage as the graduates embark on their careers as doctors, nurses, and dentists. He highlighted that every interaction, diagnosis, and decision has the potential to significantly impact lives.

Belhoul also noted the critical role the graduates now play in a field that can transform lives, emphasizing that it is during times of uncertainty that their courage will be most essential.

Drawing from his experience at the Dubai Future Foundation, he acknowledged that uncertainty and the unknown are inherent to the concept of the future. While the future remains unpredictable, he stressed that together, and with the right tools, they can navigate and make the most of the unknown.

His Excellency Dr. Amer Sharif, President of MBRU and CEO of Dubai Health said, “It is with great pride that we celebrate the achievements of MBRU's graduating Class of 2024. These exceptional graduates are poised to assume leading roles and responsibilities, not only within the UAE but also on an international scale. As students studying within Dubai Health's integrated academic health system, we are proud that our core values have been instilled throughout their studies that will see them endeavor to always put the patient first in their forthcoming professional careers."

Dr. Meznah Ali Rasheed, the graduation commencement speaker and a future physician, said: “My colleagues and I have chosen to prioritize the well-being of others. Within the walls of hospitals, we have witnessed the fragility of life and the resilience of the human spirit. Above all, we have learned what it truly means to be a doctor. My fellow graduates, the world awaits us. We are ready. We are prepared. We are the future.”

MBRU, which leads the learning and discovery missions of Dubai Health, applies a scholarly-driven ethos aimed at advancing the healthcare field and improving patient care.

Building on Dubai Health's vision to advance health for humanity, The Royal Marsden NHS Foundation Trust has been selected to support the clinical and operational development of the Hamdan Bin Rashid Cancer Hospital (HBRCH), Dubai's first integrated, comprehensive cancer hospital.

The partnership marks a significant step forward in enhancing the standard of cancer treatment in Dubai, where specialized and compassionate care will be accessible in one place.

As one of the world's leading hospitals dedicated to cancer diagnosis, treatment, research, and education, The Royal Marsden will work with Dubai Health to establish a model of excellence in comprehensive cancer care at HBRCH. Their renowned expertise will be leveraged across several key areas, including developing specialist, evidence-based models of care, early diagnosis, and treatment pathways that guide patients through every step of their journey.

The HBRCH program of care will span from early detection to treatment, recovery, and post-treatment support. A key focus of this partnership will be building a world-class, specialized team of cancer care professionals. This will involve creating a robust workforce plan, developing advanced training programmers, and fostering a culture of continuous learning. Additionally, the partnership will seek to establish a cancer research program, fostering a culture of discovering transformative advancements in cancer care.

Her Excellency Dr. Raja Easa Al Gurg, Chairperson of Al Jalila Foundation Board of Directors and Member of Dubai Health Board of Directors, said, “We are honored to join forces with The Royal Marsden, a global leader in cancer research and treatment. Their renowned expertise and approach to care perfectly complement the care, learning, discovery, and giving missions of our integrated academic health system. Through this partnership, we are honoring the collective generosity of our esteemed donors whose unwavering support to Al Jalila Foundation is fulfilling our vision for the Hamdan Bin Rashid Cancer Hospital to become a beacon of hope for patients and families facing a cancer diagnosis. It propels us closer to achieving the Dubai Social Agenda 33 goal of delivering a world-class healthcare system of the highest efficiency and quality."

Dame Cally Palmer, Chief Executive, The Royal Marsden, said: “I am delighted that The Royal Marsden has been chosen to work in partnership with Dubai Health to advance the clinical development of the Hamdan Bin Rashid Cancer Hospital. This is an excellent opportunity for international collaboration, and to adapt the best practices in state-of-the-art healthcare provision and establish the structure upon which this advanced, innovative and future-looking hospital can be based.”

“At The Royal Marsden our integrated NHS and Private Care model, underpinned by a research and academic infrastructure, delivers outstanding personalized care for our patients. Through a staged program of work, The Royal Marsden and Dubai Health aim to establish a long-term strategic partnership that will not only develop a new hospital but support specialized cancer care across the wider healthcare system in Dubai,” she added.

Set to open in 2026, the HBRCH will offer a groundbreaking model of care under Dubai Health. As part of Dubai’s first integrated academic health system, the comprehensive cancer hospital will create multidisciplinary teams to spearhead a transformative shift in care delivery. Research and clinical trials will be at the heart of the hospital, fostering a culture of discovery and accelerating progress in cancer care. With 50 clinics, 30 research areas, 60 infusion rooms, and 116 inpatient beds spread across a sprawling 56,000-square-metre campus, the hospital is positioned to become a beacon of hope for cancer patients in the UAE and the region.

Dubai Health, the first integrated academic health system in Dubai, has signed a strategic partnership agreement with the Erada Centre for Treatment and Rehab. The agreement aims to enhance collaboration between both organizations, focusing on an integrated information system, as well as medical, academic and research initiatives. The partnership specifically aims to develop an advanced model of care for patients with substance abuse disorders.

The agreement creates the framework for cooperation in a wide range of areas including patient transfer for additional medical requirements, logistical support, information exchange, training, and development. In addition, Erada will collaborate with the Mohammed Bin Rashid University of Medicine and Health Sciences to develop educational programs related to substance abuse treatment, residency, and research.

His Excellency Dr. Amer Sharif, CEO of Dubai Health, stated: “The strategic partnership with the Erada Centre for Treatment and Rehab in Dubai is part of Dubai Health’s constant efforts to further develop the healthcare system in Dubai. It reflects our commitment to enhancing medical care and rehabilitation services, guided by our four missions: Care, Learning, Discovery and Giving. Through these missions, we aim to deliver world-class healthcare services and implement international best practices, positioning Dubai as a leading global model for advancing health for humanity.”

“Apart from offering effective treatment and rehabilitation services, the Erada Centre for Treatment and Rehab in Dubai actively contributes to framing policies, strategies, and plans. It also plays a vital role in raising awareness about preventive measures, significantly contributing to the overall development of Dubai’s healthcare system. Through this strategic partnership, we aim to leverage the centre’s expertise and high-quality services to enhance the capabilities of our healthcare system, in line with our Patient First promise.”

His Excellency Abdulrazaq Amiri, CEO of the Erada Centre for Treatment and Rehab in Dubai, emphasized the Centre’s commitment to reinforcing cooperation with Dubai’s government departments to promote exchange of experiences and enhance the quality of services for both citizens and residents, particularly in the field of addiction treatment and rehabilitation. Amiri praised Dubai Health for its role as a leading health institution in the emirate, noting that its goals and vision are in line with those of the Erada Centre.

Amiri commended Dubai Health for its support in meeting the Centre’s needs for medical services that complement its addiction treatments. These include dental care, emergency case management referred by the Centre, as well as medical, pharmaceutical and laboratory services.

Furthermore, Dubai Health supports the Erada Centre’s initiatives to establish a comprehensive framework to enhance the effectiveness of treating patients with substance abuse disorder in Dubai and the rest of the country.

The partnership marks a significant milestone in strengthening the collaboration between Dubai Health and the Erada Centre for Treatment and Rehab, reflecting their shared commitment to advancing healthcare services and rehabilitation in Dubai.

Dubai Health, the first integrated academic health system in Dubai, has partnered with the Angelman Syndrome Foundation to establish the GCC’s first dedicated clinic at Al Jalila Children’s Hospital. This is the first-of-its-kind clinic in the region and aims to improve care for patients with Angelman Syndrome and raise awareness of this rare neurological disorder. The clinic will provide a supportive community hub where patients, families and caregivers can connect with experts and receive the best evidence-based care, bridging a gap in healthcare for those living with this condition.  

In line with Dubai Health’s Patient First promise, the partnership with the Angelman Syndrome Foundation represents new hope for individuals and families living with this rare neuro-genetic disorder. Affecting approximately one in 500,000 people worldwide, the early symptoms of Angelman Syndrome include a significant delay in obtaining developmental milestones such as walking within the first 12 months. Other clinical findings include speech delay, movement or balance disorder and often present with an apparent happy demeanor with frequent laughter and excitability.

The clinic will provide families in the UAE access to specialist healthcare professionals and evidence-based care while also enhancing future treatment through the power of Dubai Health’s integrated academic health system. Through harnessing the education and research that takes place within Dubai Health, this partnership aims to significantly improve the lives of patients and their families.

Dr. Abdulla Al Khayat, CEO of Al Jalila Children’s Hospital, said: “We are delighted to partner with The Angelman Syndrome Foundation to bring this specialized clinic to Al Jalila Children’s Hospital, part of Dubai Health care network. This crucial partnership is a beacon of hope for patients and families affected by this rare condition. By ensuring that we deliver the highest standard of care and driven by our Patient First promise, we hope to empower Angelman Syndrome patients and their families to lead fulfilling lives.”

Also commenting on the partnership, Amanda Moore, CEO of the Angelman Syndrome Foundation, said: "We are deeply honored to join forces with Dubai Health and Al Jalila Children's Hospital in this transformative initiative. This clinic will offer families in the UAE access to professionals with deep knowledge of Angelman Syndrome, expertise that has traditionally been challenging to locate. Raising awareness of rare conditions like Angelman Syndrome is crucial for early diagnosis and better patient outcomes. This initiative is part of our LADDER Learning Network, designed to bridge critical gaps in the healthcare landscape for families dealing with this rare disorder. We look forward to working closely with the team at Dubai Health to making a significant difference to the lives of patients and their families.”

Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), which leads the Learning and Discovery missions of Dubai Health, the first integrated academic health system in Dubai, joined forces with the United States Centers for Disease Control and Prevention (CDC) and National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH) to host the joint conference: Research and Public Health Priorities in the MENA Region: Lessons from the COVID-19 Pandemic and Future Preparedness.

Held at MBRU, the event brought together regional experts and stakeholders from the Middle East and North Africa (MENA), alongside counterparts from the U.S. and other regions to exchange insights and foster collaboration in addressing pressing public health challenges.

The U.S. CDC established the MENA Regional Office in Muscat, Oman in 2020 to strengthen public health collaborations in the region and enhance global health security. In addition to the CDC personnel in Muscat, CDC will soon place a Regional Technical Advisor for Emerging Infections and Zoonotic Diseases in Abu Dhabi to support additional efforts in UAE and the region. This presence, along with the NIAID in the region, fosters scientific and public health collaborations with the U.S., and the MENA region, including sharing best practices and innovations, such as this conference.

The conference welcomed approximately 200 delegates, including academics, healthcare practitioners, and public health professionals from 16 countries, including an impressive lineup of nearly 40 speakers and chairs and 40 abstract presenters. Featuring sessions, panel discussions, and abstract presentations, conference topics ranged from reflections on the COVID-19 pandemic's impact and predictions for future outbreaks, to strategies for preparedness and response. The conference also afforded opportunities for networking and collaboration among the participants.

The conference also featured keynotes by notable figures, including Deputy Chief of Mission Eric Gaudiosi, of the U.S. Mission to the UAE; H.E. Dr. Amer Sharif, Chief Executive Officer of Dubai Health, and President of MBRU; H.E. Professor Alawi Alsheikh-Ali, Deputy CEO of MBRU; from the U.S. Centers for Disease Control and Prevention (CDC), Dr. Henry Walke, Director of the Office of Readiness and Response, Dr. Kayla Laserson, Director for the Global Health Center, Heather Burke, Regional Director, U.S. CDC Middle East/North Africa Regional Office in Muscat, Oman, ; and from NIAID, Dr. Daniel Douek, Senior Investigator and Chief of the Human Immunology Section at the Vaccine Research Center, and Dr. Mohamed H. Sayegh, Senior Scientific Advisor to the Director.

In his opening keynote address, H.E. Dr. Amer Sharif, Chief Executive Officer of Dubai Health and President of MBRU, highlighted Dubai's proactive response to the COVID-19 pandemic, drawing upon his role as Chair of the Dubai COVID-19 Command and Control Center. He emphasized the significance of collaboration and working together in a coordinated approach toward advancing healthcare solutions.

He said, “We are proud to host healthcare leaders from all around the region and the U.S. for the Research and Public Health Priorities in the MENA Region conference here in Dubai. A new frontier of opportunities has been created since the COVID-19 pandemic, and now, more than ever, we stand at the cusp of a transformative era, where not only do we reflect upon lessons learned but also to chart new territories in a conducive environment that nurtures collaboration across the entire region and beyond. As Dubai’s first integrated academic health system, we believe that through uniting efforts, we advance health and shape a brighter future for all.”

In his opening remarks, DCM Gaudiosi stated, “Supported by the U.S. COVID-19 response supplemental funding and facilitated by the support of the U.A.E government and the U.S. diplomatic missions in the region, our gathering today focuses on health security, preparedness, and response—a testament to our shared priorities and our collective will to invest in healthier futures.”

Indeed, many of the participants were on the front lines during the COVID-19 pandemic – from clinicians, incident managers, and leaders in local, national, and global response. It was evident the importance of partnership, sharing of accurate information, forecasting and analytics to inform decision making, and health communications in protecting health not just in emergencies, but also in mass migration events and outbreak response. The conference concluded with energized participants with new and strengthened relationships and ideas for collaboration to predict, prepare, and be ready to respond to the next health threat.

Dubai Health, the first integrated academic health system in the emirate, has announced the addition of a new cohort of Emirati nurses to its team. This expansion strengthens healthcare delivery across the system and reflects Dubai Health’s commitment to nurturing and promoting local talent within the healthcare sector.

The new cohort, all graduates holding a Bachelor of Science in Nursing from the College of Health Sciences at the University of Sharjah, has been strategically placed across four locations within Dubai Health: Al Jalila Children’s Hospital, Rashid Hospital, Hatta Hospital, and Latifa Hospital.

Commenting on the announcement, His Excellency Dr. Amer Sharif, Chief Executive Officer of Dubai Health, stated: “We are proud to continue to place local talent at the heart of the frontline workforce at Dubai Health. The latest cohort of Emirati nurses brings a wealth of knowledge and a local perspective to help our integrated academic health system elevate the standard of care and advance health for humanity. We look forward to their contribution to serving Dubai and its communities.”

Khalifa Baqer, Chief Operating Officer at Dubai Health said: “The arrival of these talented Emirati nurses marks another significant milestone for Dubai Health. Their dedication and passion for healthcare delivery will undoubtedly enhance our services and patient care. We are proud to offer a supportive environment for Emirati talent and are fully committed to supporting these nurses as they contribute to our vision to advance health for humanity.”

Nursing at Dubai Health thrives with 4,300 dedicated nurses committed to advancing health. Through mentorship and development programs, Dubai Health nurtures nursing leadership, empowering nurses to drive change in healthcare. The Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), which leads the Learning and Discovery missions, offers specialized master’s programs tailored to local healthcare demands. The Master of Science in Cardiovascular Nursing and the Master of Science in Pediatric Nursing equip nurses with skills for optimal patient care, shaping the future of nursing and elevating healthcare quality.

Dubai Health, the first integrated academic health system in Dubai, is embracing virtual reality (VR) technology to improve patient care across its hospitals and healthcare centers. This initiative kicks off with a study and implementation program at the Thalassemia Center, exploring the use of VR technology to reduce anxiety and pain during cannulation (needle insertion) procedures for thalassemia patients. This study, the first of its kind for this specific patient group in Dubai, holds promise for a more comfortable and positive healthcare experience.

Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), which leads the Learning and Discovery missions of Dubai Health, will conduct and document the study. Unlike prior studies that primarily relied on subjective experiences, this novel approach will incorporate objective measurements such as eye movement tracking and heart rate to assess the effectiveness of VR technology, marking a significant advancement in medical discovery.

Dr. Fatheya Abbas Al Khaja, Director of the Thalassemia Center, expressed her profound optimism for the initiative, stating, “The application of VR technology at the Thalassemia Center has the potential to transform the experience for patients undergoing cannulation procedures. Throughout my years at the Thalassemia Center, we have explored numerous modalities to alleviate the pain of our patients. This program epitomizes our Patient First promise to provide a more comfortable and anxiety-free experience, not just for the patients, but also for their families who witness this process. We are eagerly anticipating the results of this study.”

Separate from the MBRU study, the selected VR technology had been tested extensively. It demonstrated clinically effective results in 14 published and 30 ongoing studies, providing a solid foundation for its use in improving patient experiences.

This program marks the first phase of integrating VR technology across Dubai Health hospitals and healthcare centers, with plans to extend its application into medical procedures at Al Jalila Children's Hospital and Latifa Hospital. Beyond immediate application at the Thalassemia Center, the program also focuses on developing novel VR environments and experiences tailored to the local needs of patients in Dubai. The long-term vision is to develop future iterations of AI-powered VR technology to further personalize the patient experience, a collaborative effort engaging both MBRU students and our clinical staff.

“This program is the first of many to showcase how digital solutions can improve patient care within Dubai Health,” remarked Dr. Yacine Hadijat, Associate Professor of Innovation in Health Science and Digital Health at MBRU’s College of Medicine. “One of the inherent advantages of our integrated academic health system is the ability to cultivate a continuous cycle of improvement within our care, learning and discovery missions. By exploring digital innovations, such as VR technology, we are simultaneously training future healthcare professionals to champion patient-centered care and contribute toward the medical discovery of tech-enabled healthcare solutions. This multifaceted approach holds immense promise to transform the patient journey for countless individuals.”

By spearheading such initiatives, Dubai Health remains at the forefront of healthcare innovation, reaffirming its commitment to delivering patient-centered care and advancing the standard of medical excellence in the region.

Surgeons at Dubai Health have announced a groundbreaking achievement: the successful removal of the world's largest adrenal tumor at Dubai Hospital. Dubai Hospital's multidisciplinary approach to the surgery, which forms part of the emirate's first integrated academic health system, ensured the best possible outcome. The successful surgery also reflects Dubai Health's promise to put the Patient First. 

The 69-year-old patient, previously in good health, was referred to the hospital's emergency unit due to a massive abdominal mass discovered during a scan. Struggling with walking and breathing for months prior to surgery, the patient's condition necessitated immediate specialized care.

Specialists from various disciplines across Dubai Health gathered at Dubai Hospital to deduce the best course of action for the patient. The four-hour procedure was performed by a multidisciplinary team of experts from urology, oncology, radiology, interventional radiology, vascular surgery, general surgery, and anesthesia. Measuring 27 x 26 cm and weighing 9.4 kilograms, the tumor’s size and weight surpassed all previous records.

Dr. Fariborz Bagheri, Consultant Urologist at Dubai Hospital, who led the operation, highlighted the complexity and risks associated with the procedure. "Due to the tumor's size and its compression on vital structures, surgical intervention posed considerable challenges," stated Dr. Fariborz. "However, without intervention, the patient's survival was at high risk." 

Reflecting on the outcome, Dr. Fariborz expressed gratitude for the successful procedure, attributing it to the combined efforts of the medical and surgical teams. He further commented, "We are very thankful that the patient responded well to the surgery and has fully recovered."

Dr. Mariam Al Raeesi, CEO of Dubai Hospital, highlighted the collaborative efforts of the multidisciplinary team in deciding to proceed with the surgery. "After careful consideration and collaboration among our medical and surgical experts, it was agreed to undertake this complex procedure," Dr. Al Raeesi said. "The enormous success of the procedure is a huge testament to our medical staff here at Dubai Hospital, putting in practice our Patient First promise focused on delivering high-quality care for patients."

Dubai Hospital is one of the largest specialized tertiary hospitals in the UAE. As part of Dubai Health, the first integrated academic health system in Dubai, the hospital provides comprehensive services in all healthcare disciplines, relevant to the needs of the community.

A delegation from UMass Chan Medical School, Massachusetts’s first and only public academic health sciences center, recently visited Dubai Health, solidifying a new chapter in healthcare collaboration between the two organizations. The visit, marked by the signing of a Memorandum of Understanding (MOU), granted the delegation the opportunity to gain insight into Dubai’s first integrated academic health system, laying the groundwork for a productive partnership.

Inspired by UMass Chan’s reputation for impact through collaborative endeavour and aspiration to change the course of the history of disease, the partnership reflects a shared vision between the two academic health systems to advance health. Under the agreement, UMass Chan and Dubai Health will establish mutually beneficial research projects to improve patient care, create an exchange framework for learners between the two academic institutions, and drive transformative advancements for public health, both locally and globally.

Led by Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor at UMass Chan, the visit also included an opportunity for Dubai Health learners to gain insight into elective and residency program opportunities at UMass Chan.

Commenting on the partnership, Professor Alawi Alsheikh-Ali, Deputy CEO and Chief Academic Officer of Dubai Health, and Provost of MBRU, stated, “This collaboration presents an exciting opportunity to combine the strengths of two academic health organizations. By pooling our resources, capabilities, and expertise, we are well-positioned to advance the frontier of medical knowledge that better serves our communities. The visit has been incredibly productive, laying the foundation for meaningful collaboration anchored in our shared purpose of advancing health for humanity.”

Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor of UMass Chan commented “It is a privilege, along with a group of senior colleagues, to learn more about the breadth and depth of activity taking place at Dubai Health and to forge closer relationships with its leadership. The signing of an MOU between our respective institutions is an exciting development and provides UMass Chan and Dubai Health with a framework from which to pursue meaningful collaborations and exchanges, by partnering, we do hope to advance together on behalf of the communities that we serve.”

The UMass Chan delegation included Michael F. Collins, MD, Senior Vice President for Health Sciences and Chancellor; Terence R. Flotte, MD, Provost, Dean, and Executive Deputy Chancellor; David D. McManus, MD, Chair, Department of Medicine; Anne Larkin, MD, Associate Professor of Surgery, Vice Provost, and Senior Associate Dean for Educational Affairs; Lisa Colombo, DNP, MHA, RN, Executive Vice Chancellor and CEO, ForHealth Consulting; Rebekah Diamond, JD, Executive Director, Business Strategy & Operational Excellence, ForHealth Consulting; Brendan Chisholm, Vice Chancellor of Management, Chief of Staff, Office of the Chancellor.

April 04, 2024, Dubai: Al Jalila Foundation, which leads the giving mission of Dubai Health, announced that Saeed Ahmed Lootah Charity Foundation has donated AED 15 million to support the development of the Hamdan Bin Rashid Cancer Hospital, Dubai's first integrated, comprehensive cancer hospital. This donation underscores Saeed Ahmed Lootah Charity Foundation's commitment to advancing sustainable charitable and humanitarian work and reinforcing Dubai's pioneering role in healthcare excellence.

Set to open in 2026, the hospital honors the legacy of the late Sheikh Hamdan bin Rashid Al Maktoum, paying tribute to his lifetime of service to the nation and extraordinary global philanthropic activities that continue to touch the lives of many around the world. The hospital is being developed with the support of generous donations received from philanthropists, government and non-government organizations, UAE businesses and corporates.

Engineer Hussain Nasser Lootah, Member of the Board of Trustees of the Saeed Ahmed Lootah Charity Foundation, said: “Inspired by our visionary leadership, which has embedded philanthropy into its core humanitarian strategies, the Saeed Ahmed Lootah Charity Foundation, led by H.E. Lieutenant General Dhahi Khalfan Tamim, Chairman of the Board of Trustees, remains committed to social responsibility, education, and medical research support. We are pleased to contribute towards the Hamdan Bin Rashid Cancer Hospital, aligning our efforts with Al Jalila Foundation to ensure equitable and essential access to cancer care. This partnership reflects the core principles of our esteemed founder, Haj Saeed Ahmed Lootah, who championed education, healthcare, and scientific research. Our dedication extends beyond borders, encompassing local and global charitable and humanitarian endeavors."

Dr. Thani Al Mheriri, CEO of Education & Health at Saeed Ahmed Lootah Charity Foundation, said: “By joining hands, we aim to make a meaningful impact in the fight against cancer and advancing medical research. Our dedication to medical education and healthcare is deeply rooted in our legacy; Dubai Medical College for Girls, which was established forty years ago as the first institution for medical education for girls in the Gulf region, is now a prominent contributor to the healthcare landscape."

Dr. Amer Al Zarooni, CEO of Al Jalila Foundation, said: “Donor support is an integral part of our success in developing the Hamdan Bin Rashid Cancer Hospital. We are grateful to Saeed Ahmed Lootah Charity Foundation, which has committed to helping us support cancer patients and their families. The hospital will bring together cancer expertise and make an invaluable contribution to Dubai’s healthcare sector, putting patient care first.”

"Together, we are one step closer to establishing a center of excellence that will transform cancer care in the UAE." he added.

The 116-bed hospital will occupy 56,000 square meters. It will provide best-in-class outpatient, ambulatory and diagnostic services as well as inpatient and surgical services in a nurturing environment that features personalized patient care.

As part of Dubai Health, the first integrated academic health system in Dubai, the comprehensive cancer hospital will benefit from a multidisciplinary team, including specialized nursing, offering patients a full spectrum of care services in one location, from early diagnosis to treatment and supportive care. Aligning with Dubai Health’s Patient First promise, select treatments and services will be made available to patients in the comfort of their homes, ensuring an easy and accessible continuum of care.

For more information on Al Jalila Foundation and its programs, please visit:
https://www.aljalilafoundation.ae

On the occasion of Zayed Humanitarian Day, Dubai Health, the first integrated academic health system in Dubai, today inaugurated 'The Clinic of Hope' at Al Jalila Children’s Hospital. The charitable multi-specialty pediatric clinic is dedicated to providing essential healthcare services to children who lack access to adequate medical care.

Driven by Dubai Health’s ‘Patient First’ promise, the Clinic is committed to ensuring that every child receives the high-quality healthcare they deserve, regardless of their socio-economic background. With a steadfast focus on compassion and excellence, a team of dedicated pediatric healthcare professionals stands ready to serve those in need.

His Excellency Dr. Amer Sharif, Chief Executive Officer of Dubai Health said: “We are both proud and humbled to inaugurate ‘The Clinic of Hope’ on Zayed Humanitarian Day, as we reflect on the enduring legacy of the late Sheikh Zayed bin Sultan Al Nahyan, whose visionary leadership and compassion have left an indelible mark on the world. At Dubai Health, we reaffirm our dedication to carrying forward his legacy by providing care to all and by extending our support to those in need. The launch of this new clinic aligns with our mission to impact lives through a ‘Patient First’ promise, ensuring that accessible and quality healthcare is provided across the continuum of care.”

Dr. Mohamed Alawadhi, Deputy CEO of Al Jalila Children’s Hospital and Latifa Hospital said: “The inauguration of ‘The Clinic of Hope’ represents a significant step forward in our ongoing commitment to serving the healthcare needs of all children in our community. We believe that every child deserves access to essential healthcare services, and ‘The Clinic of Hope’ will play a vital role in ensuring that this vision becomes a reality. Through collaborative efforts with partners and stakeholders, we will create a healthier and more inclusive community for all children in Dubai.”

The inauguration event received support from the Community Development Authority and Awqaf Dubai, which played a pivotal role in identifying vulnerable children within the community. This collaboration further strengthened Dubai Health's collective efforts to reach those in need. During the event, the Clinic provided a range of essential health services, including medical examinations, diagnoses, as well as nutritional and dental education tailored specifically for children. To enrich the experience of young patients, the Emirates Literature Foundation organized several reading activities.

Established to enhance the standard of care and advance health for humanity, Dubai Health is the first integrated academic health system in Dubai. It encompasses six hospitals, 26 ambulatory health centers, 20 medical fitness centers, the Mohammed Bin Rashid University of Medicine and Health Sciences, and Al Jalila Foundation. With a focus on integrating care, learning, discovery, and philanthropy, 11,000 employees collaborate across multidisciplinary teams to prioritize patient care.

Al Jalila Foundation, which leads the giving mission of Dubai Health, the first integrated academic health system in Dubai, announced that Meem Foundation, a Dubai-based philanthropic organization, has generously donated AED 3 million to support medical education and treatment programs to empower women and girls.

Aligned with Meem Foundation's values of creating pathways for women and girls to achieve economic empowerment and access to healthcare, the donation is earmarked for medical scholarships for aspiring female students, providing them with the opportunity to pursue careers in healthcare and medical treatments tailored for women, including mothers and children, ensuring access to essential healthcare services.

Muna Easa Al Gurg, Emirati businesswoman, philanthropist, and founder of Meem Foundation, said: "We invest in strategic philanthropic initiatives in the MENA region to address issues impacting the lives of women and girls while helping to bridge the gender gap. Our partnership with Al Jalila Foundation is a testament to our commitment. Together, we aim to empower aspiring young women to pursue their educational goals and accelerate their medical careers. Our partnership will also support patient treatment programs for women and girls, ensuring that health is never a barrier to achieving their dreams. At Meem Foundation, we envision a future where every woman and girl has the opportunity to thrive, irrespective of the challenges they face."

Dr. Amer Al Zarooni, CEO of Al Jalila Foundation, said: “For over a decade, Al Jalila Foundation has made a significant impact on lives through its patient treatment programs, medical scholarships and research grants. Our collaboration with Meem Foundation exemplifies the collective effort needed to deliver life-transforming health programs. The funds received will enable us to support women and girls, empowering them to step into a more promising tomorrow.”

Meem Foundation is a Dubai-based organization committed to finding innovative entrepreneurial solutions to gender inequality, aligned with the UN Sustainable Development Goal (SDG) 5. It is committed to creating sustainable solutions that uplift women and girls, empowering them to thrive in all aspects of life.

Dubai Health, the first integrated academic health system in Dubai, was established to elevate the standard of care and to advance health for humanity. Dubai Health comprises six hospitals, 27 ambulatory health centers, 20 medical fitness centers, Mohammed Bin Rashid University of Medicine and Health Sciences, and Al Jalila Foundation. Through the integration of care, learning, discovery, and giving, eleven thousand employees collaborate across multidisciplinary teams to put the patient first.

For more information on Al Jalila Foundation and its programs, please visit:
https://www.aljalilafoundation.ae

Dubai Health is thrilled to announce that more than 10% of faculty members at Mohammed Bin Rashid University of Medicine and Health Sciences have been recognized and placed on the World’s Top 2% of Scientists list by Stanford University in the subfields of Dentistry, Obstetrics & Reproductive Medicine, Genetics & Heredity, and Gastroenterology & Hepatology. This list represents the top 2 percent of the most-cited researchers worldwide.

Moreover, MBRU takes immense pride in highlighting that Professor Momen Atieh, the Chair - Oral Diagnostics and Surgical Sciences at the Hamdan Bin Mohammed College of Dental Medicine, has earned the top national position in Dentistry in the United Arab Emirates.

• Cardiovascular System & Hematology: Professor Nandu Goswami
• Dentistry: Professor Momen Atieh, Professor Keyvan Moharamzadeh, the late Professor Dimitrius Tziafas,
• Gastroenterology & Hepatology: Professor Samuel Ho, Professor Thomas Adrian
• General & Internal Medicine: Professor Lakshmanan Jeyaseelan
• Genetics and Hereditary: Dr. Ahmad Abou Tayoun, Dr. Mohammed Uddin
• Obstetrics & Reproductive Medicine: Professor Stefan Du Plessis

These faculty members have demonstrated unparalleled dedication to research, education, and clinical practice, contributing significantly to the global advancement of medical knowledge. Their recognition in the Stanford University scientist rankings is a testament to the caliber of talent fostered at Mohammed Bin Rashid University of Medicine and Health Sciences.

About World’s Top 2% Scientist Rankings by Stanford University
The World’s Top 2% Scientist Rankings by Stanford University is a prestigious index that recognizes the top scientists across various disciplines worldwide. Researchers are classified into 22 scientific fields and 174 sub-fields based on Science-Metrix's established classification, drawing from Scopus data provided by Elsevier through ICSR Lab.

Dubai Health, the first integrated academic health system in Dubai, has announced the opening of applications for its graduate training programs offered by the Graduate Medical Education (GME) at Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU).

The GME at MBRU offers an extensive range of training opportunities, including two internship programs, 20 residencies, and 15 fellowships spanning medical, dental, and surgical specialties. These programs have earned accreditation from key regional accreditation bodies, including the Saudi Commission for Health Specialties, the UAE National Institute for Health Specialties, and the Arab Board of Health Specializations.

Professor Sulaiman Alemran, Dean of Graduate Medical Education, commented: “As Dubai’s first academic health system, through the integration of care, learning, discovery, and giving, we have a unique opportunity to create an engine for innovation, connected for the patient - delivered through a culture of collaboration. We believe that through instilling this transformative mindset and uniting as one, we can advance health to new heights of patient-centric excellence. Leveraging the integrated academic health system of Dubai Health, our trainees have the unique opportunity to directly engage with patients across 6 hospitals, 27 ambulatory health centers, and 20 medical fitness centers at with Dubai Health.”

Dr. Rasha Buhumaid, Vice Dean and Designated Institutional Official at Graduate Medical Education and Assistant Professor of Emergency Medicine at MBRU said, "We offer 250 seats annually for enrollment in our graduate medical education programs. Our programs are designed to equip emerging healthcare professionals with well-rounded skills, ensuring their preparedness for the dynamic professional landscape. Trainees will benefit from experienced and dedicated faculty and clinical educators and partake in innovative research within their specialized field of interest, contributing to advancing medical knowledge. This approach aims to guarantee the quality of healthcare provided by future healthcare professionals, fostering a commitment to excellence and quality in their practice."

Registration for Graduate Medical Education (GME) at MBRU is currently open, with a deadline of March 22nd for residency programs. For internship and fellowship programs, the registration period extends until April 22nd.

To learn more and submit an application, please visit: https://www.mbru.ac.ae/graduate-medical-education/

Dubai Health, the first integrated academic health system in Dubai, has announced the inauguration of the Center for Prenatal Pediatrics, supported by Al Tayer Group. Located at Latifa Hospital, the new Center will manage high-risk pregnancies and deliver specialized care and monitoring for expecting mothers.

The inauguration ceremony was attended by H.E. Dr. Raja Easa Al Gurg, Chairperson of Al Jalila Foundation Board of Directors and Dubai Health Board Member, H.E. Dr. Amer Sharif, CEO of Dubai Health, Dr. Muna Tahlak, Chief Medical Officer at Dubai Health and CEO of Latifa Hospital, and Mr. Ahmed Al Tayer, Director of Al Tayer Group, alongside several senior officials of both entities.

Al Tayer Group has generously contributed 4 million dirhams through Al Jalila Foundation, which leads the giving mission of Dubai Health to establish the Center in honor of Shaikha Abdula bin Kalban. This contribution aims to bolster Dubai Health's commitment to delivering patient-centered care through its integrated academic health system.

The new Center is equipped with advanced, high-precision technology to ensure comprehensive care for the most complex and sensitive cases. From pregnancy to childbirth, a multidisciplinary team of pediatric and obstetrics specialists provides continuous care and monitoring for both mother and child, aiming to minimize future health issues.

H.E. Dr. Raja Easa Al Gurg, Chairperson of Al Jalila Foundation Board of Directors and Dubai Health Board Member, commended the inauguration of the Center, stating, "We are pleased to collaborate with Al Tayer Group, whose generous donations have been fundamental in opening the Center for Prenatal Pediatrics. Through this partnership, we aim to enhance the well-being of families and contribute to the overall health of the community, in alignment with Dubai Health’s commitment to elevate the standard of care advancing health for humanity.”

Ahmed Al Tayer, Director of Al Tayer Group, said: “As a family, we are privileged to have the opportunity to give back to the UAE, a nation that continues to invest significantly in its people. Prioritizing the wellbeing of future generations, world-class healthcare is a focal point for both Dubai and the UAE. We take pride in furthering the legacy outlined by the country’s visionary leadership.”

“In line with Al Tayer’s Philanthropic philosophy to focus and support initiatives related to medical advancement and children, we are happy to support this project by Latifa Hospital and Al Jalila Foundation. The inauguration of the Center for Prenatal Pediatrics at Latifa Hospital signifies an innovative new milestone in healthcare, redefining the benchmarks of pediatric and prenatal expertise in the region. We feel confident that under the Dubai Health leadership team, the Center will not only give the patients unparalleled care but will also set the platform of future collaborative research and development in the field of prenatal pediatrics”.

Dr. Muna Tahlak, Chief Medical Officer at Dubai Health and CEO of Latifa Hospital, said, "Equipped with the latest technology and expertise, the Center for Prenatal Pediatrics serves as a proactive response to the escalating demand for advanced prenatal care. The Center is a valuable addition to our academic health system, providing specialized care for expectant mothers and their children facing critical conditions. Moreover, the Center holds tremendous potential to emerge as a hub for discovery, fostering research and innovation specifically focused on advancing prenatal care and managing these challenging cases."

The Center for Prenatal Pediatrics will begin receiving cases on 12 February 2024.

His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai and Chairman of The Executive Council of Dubai attended a ceremony unveiling the design of the Hamdan Bin Rashid Cancer Hospital, part of Dubai Health. Set to be Dubai's first integrated, comprehensive cancer hospital, the event also announced the hospital's groundbreaking model of care.

Marking a significant step in terms of providing advanced and accessible cancer care, Dubai Health announced that the Hamdan Bin Rashid Cancer Hospital is to open in 2026. The hospital honors the legacy of the late Sheikh Hamdan bin Rashid Al Maktoum, paying tribute to his lifetime of service to the nation and extraordinary global philanthropic activities that continue to touch the lives of many around the world.

The ceremony was held at the site allocated for the hospital in the presence of His Highness Sheikh Ahmed bin Saeed Al Maktoum, Chairman of the Dubai Health Board of Directors; His Highness Sheikh Mansoor bin Mohammed bin Rashid Al Maktoum, Vice Chairman of the Dubai Health Board of Directors; and Sheikh Rashid bin Hamdan bin Rashid Al Maktoum, President of the Hamdan bin Rashid Al Maktoum Establishment for Medical and Educational Sciences.

His Excellency Awadh Seghayer Al Ketbi, Director General of Dubai Health Authority (DHA); Her Excellency Dr. Raja Easa Al Gurg, Chairperson of Al Jalila Foundation Board of Directors and Dubai Health Board Member, and His Excellency Dr. Amer Ahmad Sharif, CEO of Dubai Health also attended the ceremony among other officials and donors.

The Hamdan Bin Rashid Cancer Hospital is being developed with the aid of generous donations received through Al Jalila Foundation, which leads Dubai Health's giving mission. The collective contributions of individuals and organizations will support the establishment of the 56,000²m hospital.

Reflection of Dubai Social Agenda 33
HH Sheikh Hamdan said, "The Hamdan Bin Rashid Cancer Hospital honors the humanitarian legacy of the late Sheikh Hamdan bin Rashid Al Maktoum. This new addition to the health system in Dubai will play a crucial role in achieving the Dubai Social Agenda 33 goal to deliver the most efficient world-class healthcare system of the highest quality."
HH Sheikh Hamdan thanked all donors who had contributed to the hospital project, highlighting their support as invaluable contributions to building the future of Dubai and its healthcare sector.

Beacon of hope
HH Sheikh Ahmed said, "The Hamdan Bin Rashid Cancer Hospital is a fitting tribute to the late Sheikh Hamdan Bin Rashid Al Maktoum, resonating with his belief that helping others was not just a duty but a blessing. The Hamdan Bin Rashid Cancer Hospital will stand as a beacon of hope, a hub of innovation, and a promise to provide excellent care to our patients in Dubai and beyond. With some of the world's leading experts, cutting-edge technology, and a compassionate approach, we will create an environment that fosters healing and resilience in the region."

HH Sheikh Mansour said, "The Hamdan Bin Rashid Cancer Hospital will break new ground in elevating cancer care standards, reaffirming Dubai Health's commitment to advancing health for humanity. Together, we will honor the legacy of the late Sheikh Hamdan Bin Rashid Al Maktoum and realize Dubai's ambition to be a global leader in healthcare innovation, ensuring access to world-class medical services for all."

The hospital, located in the Al Jaddaf area, is envisaged to host 50 clinics, 30 clinical research areas, 60 infusion rooms, 10 urgent care rooms, 5 radiotherapy rooms, and 116 inpatient beds. Enhancing the healing environment for patients and their families will be 19 gardens distributed across the hospital campus. Stantec, a global leader in sustainable design and engineering, has been appointed as the architect for the project.

As part of Dubai Health, the first integrated academic health system in Dubai, the comprehensive cancer hospital will benefit from a multidisciplinary team, including specialized nursing, offering patients a full spectrum of care services in one location, from early diagnosis to treatment and supportive care. Aligning with Dubai Health's 'Patient First' promise, select treatments and services will be made available to patients in the comfort of their homes, ensuring an easy and accessible continuum of care.  

HE Dr. Raja Easa Al Gurg said, "We extend our deepest gratitude to all our generous donors for upholding the spirit of giving, echoing the legacy of the late Sheikh Hamdan bin Rashid Al Maktoum. The hospital is a collective endeavor, a testament to our shared humanity, uniting us against a global challenge."

New model of care
The hospital will spearhead a transformative shift in care delivery, moving from a traditional inpatient model to an ambulatory model of care. This shift includes integrating primary care with diagnosis and treatment to offer detection and intervention at earlier stages of the patient's journey.

Research and clinical trials will be at the heart of the hospital's array of services, fostering opportunities for discovering the best patient outcomes through personalized, patient-centric, evidence-based care.